Literature DB >> 2779414

A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA.

C W Grant1, S Karlik, E Florio.   

Abstract

The chelating agent, diethylenetriaminepentaacetic acid (DTPA), was attached via one -COOH group to the amino headgroup of phosphatidylethanolamine to produce a phospholipid which is also a powerful chelating agent. It readily assembles into the walls of lipid bilayer structures as a liposome-associated carrier of cations for MR contrast or radioisotope studies. Freeze-etch electron microscopy showed that phosphatidylethanolamine-DTPA formed satisfactory sonicated vesicles when mixed with natural phospholipids at up to 50 wt%. The resultant structures with bound gadolinium effectively shortened T1 and T2 of surrounding water protons. When sonicated liposomes bearing chelating agent with bound 111In3+ were injected intravenously into rats, uptake was primarily by liver and spleen. By 24 h postinjection there was biliary excretion of this material. Phosphatidylethanolamine-DTPA may have some general utility as an amphiphilic liposomal chelating agent for polyvalent cations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2779414     DOI: 10.1002/mrm.1910110211

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  14 in total

Review 1.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

Review 2.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Novel chelate-induced magnetic alignment of biological membranes.

Authors:  R S Prosser; V B Volkov; I V Shiyanovskaya
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

4.  Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.

Authors:  Srinivas Ganta; Amit Singh; Yashesh Rawal; Joseph Cacaccio; Niravkumar R Patel; Praveen Kulkarni; Craig F Ferris; Mansoor M Amiji; Timothy P Coleman
Journal:  Drug Deliv       Date:  2014-06-05       Impact factor: 6.419

Review 5.  Micellar nanocarriers: pharmaceutical perspectives.

Authors:  V P Torchilin
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

6.  Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.

Authors:  Vladimir P Torchilin; Anatoly N Lukyanov; Zhonggao Gao; Brigitte Papahadjopoulos-Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 7.  New magnetic resonance imaging techniques for the detection of breast cancer.

Authors:  K Orang-Khadivi; B L Pierce; C M Ollom; L J Floyd; R L Siegle; R F Williams
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Authors:  Vladimir P Torchilin
Journal:  AAPS J       Date:  2007-05-11       Impact factor: 4.009

Review 9.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

10.  Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer.

Authors:  Srinivas Ganta; Amit Singh; Niravkumar R Patel; Joseph Cacaccio; Yashesh H Rawal; Barbara J Davis; Mansoor M Amiji; Timothy P Coleman
Journal:  Pharm Res       Date:  2014-03-19       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.